These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15713967)

  • 21. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HUPO proteomics standards initiative--overcoming the fragmentation of proteomics data.
    Hermjakob H
    Proteomics; 2006 Sep; 6 Suppl 2():34-8. PubMed ID: 17031794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AACR-FDA-NCI cancer biomarkers collaborative.
    Yu LR; Veenstra TD
    Expert Rev Mol Diagn; 2007 Sep; 7(5):507-9. PubMed ID: 17892359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The amplified peptidome: the new treasure chest of candidate biomarkers.
    Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP
    Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in mass spectrometry for the analysis of complex protein mixtures.
    Khalsa-Moyers G; McDonald WH
    Brief Funct Genomic Proteomic; 2006 Jun; 5(2):98-111. PubMed ID: 16772276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive proteomic analysis of the human milk proteome: contribution of protein fractionation.
    Mangé A; Bellet V; Tuaillon E; Van de Perre P; Solassol J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):252-6. PubMed ID: 19019742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Omenn GS; States DJ; Adamski M; Blackwell TW; Menon R; Hermjakob H; Apweiler R; Haab BB; Simpson RJ; Eddes JS; Kapp EA; Moritz RL; Chan DW; Rai AJ; Admon A; Aebersold R; Eng J; Hancock WS; Hefta SA; Meyer H; Paik YK; Yoo JS; Ping P; Pounds J; Adkins J; Qian X; Wang R; Wasinger V; Wu CY; Zhao X; Zeng R; Archakov A; Tsugita A; Beer I; Pandey A; Pisano M; Andrews P; Tammen H; Speicher DW; Hanash SM
    Proteomics; 2005 Aug; 5(13):3226-45. PubMed ID: 16104056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
    DeSouza LV; Romaschin AD; Colgan TJ; Siu KW
    Anal Chem; 2009 May; 81(9):3462-70. PubMed ID: 19323455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Place of pattern in proteomic biomarker discovery.
    Gillette MA; Mani DR; Carr SA
    J Proteome Res; 2005; 4(4):1143-54. PubMed ID: 16083265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.